» Articles » PMID: 37083461

Effects of Mixed Nut Consumption on Blood Glucose, Insulin, Satiety, and the Microbiome in a Healthy Population: A Pilot Study

Overview
Journal J Med Food
Date 2023 Apr 21
PMID 37083461
Authors
Affiliations
Soon will be listed here.
Abstract

Nuts contain many health-promoting nutrients, fiber, and phytochemicals. Nut consumption has been reported to improve several chronic disease risk factors. Most studies to date have investigated single variety nut consumption. A nut mixture may offer a more diverse array of nutrients over single variety nuts. The primary outcome of this study was to examine the effects of mixed nut consumption on postprandial glucose, insulin, and satiety in healthy young adults. Exploratory outcomes include the effects of daily nut consumption on stool microbiome and bowel movement patterns. Twenty participants were randomized to consume either 42 g of mixed nuts or 46 g of potato chips daily for 3 weeks. Mixed nut consumption did not alter postprandial blood glucose and insulin, while potato chip consumption increased glucose and insulin ( < .05). There were no significant differences in fasting blood glucose or insulin for either snack after 3 weeks of daily consumption. Both snacks increased satiety while there were no significant differences in body weight, body fat, blood pressure, waist-to-hip ratio, or anxiety. After 3 weeks of snack consumption, both groups significantly reduced straining during bowel movements while the mixed nut group slightly increased stool amount. There were no significant changes in microbiome composition for either group; however, there was a nonsignificant trend toward increased Firmicutes to Bacteroidetes ratio in the potato chip group and an opposite trend in the mixed nut group. The results of this study suggest that mixed nuts are a healthy alternative for blood sugar control. The study was registered at ClinicalTrials.gov, Number: NCT03375866.

Citing Articles

Relationship with Nut Consumption for Breakfast and Postprandial Glucose, Insulin, Triglyceride Responses: A Preliminary Study from Türkiye.

Ozger I, Kose G, Bas M, Oruc S, Hajhamidiasl L, Yilmaz S Foods. 2024; 13(20).

PMID: 39456351 PMC: 11508106. DOI: 10.3390/foods13203289.

References
1.
Zhang L, Davies S . Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med. 2016; 8(1):46. PMC: 4840492. DOI: 10.1186/s13073-016-0296-x. View

2.
Torabian S, Haddad E, Rajaram S, Banta J, Sabate J . Acute effect of nut consumption on plasma total polyphenols, antioxidant capacity and lipid peroxidation. J Hum Nutr Diet. 2009; 22(1):64-71. DOI: 10.1111/j.1365-277X.2008.00923.x. View

3.
Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P . The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients. 2020; 12(5). PMC: 7285218. DOI: 10.3390/nu12051474. View

4.
Flint A, Raben A, Blundell J, Astrup A . Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000; 24(1):38-48. DOI: 10.1038/sj.ijo.0801083. View

5.
Castaner O, Goday A, Park Y, Lee S, Magkos F, Shiow S . The Gut Microbiome Profile in Obesity: A Systematic Review. Int J Endocrinol. 2018; 2018:4095789. PMC: 5933040. DOI: 10.1155/2018/4095789. View